Literature DB >> 18063488

A mycolyl transferase mutant of Rhodococcus equi lacking capsule integrity is fully virulent.

Tobias Sydor1, Kristine von Bargen, Ulrike Becken, Sabine Spuerck, Vivian M Nicholson, John F Prescott, Albert Haas.   

Abstract

Rhodococcus equi is a mucoid Gram-positive facultative intracellular pathogen which can cause severe bronchopneumonia in foals and AIDS patients. A polysaccharide capsule which gives R. equi a mucoid appearance has long been suspected to be a virulence factor. Here, we describe a transposome mutant in the gene fbpA of strain R. equi 103 causing absence of a capsular structure. FbpA is a chromosomal gene homologous to antigen 85 (Ag85) mycolyl chain transferase gene of Mycobacterium tuberculosis. The mutant multiplied normally in isolated macrophages, was able to establish the unusual R. equi-containing vacuole in macrophages, was cytotoxic for macrophages, and was virulent in a mouse model. Colonies had a dry appearance on nutrient agar and defective capsule structure. Surprisingly, fbpA mutants cured of the virulence-associated plasmid were found in a phagosome that was more alkaline than that of the corresponding wild-type bacteria, were more cytotoxic and even multiplied to some extent. This study suggests that the capsule is not an important virulence factor of R. equi and that it may even counteract virulence traits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063488     DOI: 10.1016/j.vetmic.2007.10.020

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  8 in total

1.  Trimeric autotransporter adhesin-dependent adherence of Bartonella henselae, Bartonella quintana, and Yersinia enterocolitica to matrix components and endothelial cells under static and dynamic flow conditions.

Authors:  Niklas F Müller; Patrick O Kaiser; Dirk Linke; Heinz Schwarz; Tanja Riess; Andrea Schäfer; Johannes A Eble; Volkhard A J Kempf
Journal:  Infect Immun       Date:  2011-05-02       Impact factor: 3.441

2.  In vitro potential of equine DEFA1 and eCATH1 as alternative antimicrobial drugs in rhodococcosis treatment.

Authors:  Margot Schlusselhuber; Sascha Jung; Oliver Bruhn; Didier Goux; Matthias Leippe; Roland Leclercq; Claire Laugier; Joachim Grötzinger; Julien Cauchard
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

3.  Nitric oxide-mediated intracellular growth restriction of pathogenic Rhodococcus equi can be prevented by iron.

Authors:  Kristine von Bargen; Jens Wohlmann; Gregory Alan Taylor; Olaf Utermöhlen; Albert Haas
Journal:  Infect Immun       Date:  2011-03-07       Impact factor: 3.441

4.  Molecular characterization of Rhodococcus equi from horse-breeding farms by means of multiplex PCR for the vap gene family.

Authors:  Fernanda Monego; Franciele Maboni; Cristina Krewer; Agueda Vargas; Mateus Costa; Elgion Loreto
Journal:  Curr Microbiol       Date:  2009-02-10       Impact factor: 2.188

5.  Rhodococcus equi virulence-associated protein A is required for diversion of phagosome biogenesis but not for cytotoxicity.

Authors:  Kristine von Bargen; Marco Polidori; Ulrike Becken; Gitta Huth; John F Prescott; Albert Haas
Journal:  Infect Immun       Date:  2009-09-21       Impact factor: 3.441

6.  Non-Coding RNAs are Differentially Expressed by Nocardia brasiliensis in Vitro and in Experimental Actinomycetoma.

Authors:  Josué S Cruz-Rabadán; Juan Miranda-Ríos; Guadalupe Espín-Ocampo; Luis J Méndez-Tovar; Héctor Rubén Maya-Pineda; Francisca Hernández-Hernández
Journal:  Open Microbiol J       Date:  2017-06-30

7.  Strain-to-strain variation of Rhodococcus equi growth and biofilm formation in vitro.

Authors:  Adina R Bujold; Nicholas R Lani; Macarena G Sanz
Journal:  BMC Res Notes       Date:  2019-08-19

8.  Diversion of phagosome trafficking by pathogenic Rhodococcus equi depends on mycolic acid chain length.

Authors:  Tobias Sydor; Kristine von Bargen; Fong-Fu Hsu; Gitta Huth; Otto Holst; Jens Wohlmann; Ulrike Becken; Tobias Dykstra; Kristina Söhl; Buko Lindner; John F Prescott; Ulrich E Schaible; Olaf Utermöhlen; Albert Haas
Journal:  Cell Microbiol       Date:  2012-11-13       Impact factor: 3.715

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.